Birth Control Pills: Cancer Risk Facts and IARC Classification

Health Medicine

Aug 11, 2026 · 4 min read

Birth Control Pills: Cancer Risk Facts and IARC Classification

Combined birth control pills, containing both oestrogen and progestogen, are widely used for their convenience and effectiveness. However, they have been classified as Group 1 carcinogens by the IARC, indicating a known risk to humans, along with other substances such as asbestos and tobacco.

Source

Watch the Reel

Birth Control Pills and Cancer Risks

Birth control pills, specifically combined oestrogen-progestogen oral contraceptives, have been a topic of significant medical scrutiny due to their association with cancer risks. There is a wealth of evidence supporting this correlation. Understanding the nature of these risks is essential for anyone considering or currently using oral contraceptives.

Why this Matters

The International Agency for Research on Cancer (IARC) was the first to classify combined oral contraceptives as Group 1 carcinogens. This classification places them in the same category as substances like asbestos and tobacco, known for their significant carcinogenic effects on humans. This designation underscores the importance of being informed about the potential risks associated with these contraceptives.

Oestrogen-Progestogen Oral Contraceptives: Their Role and Risks

What Are Combined Oral Contraceptives?

Combined oral contraceptives contain both oestrogen and progestogen, two types of hormones that work together to prevent pregnancy. These formulations are widely used due to their effectiveness and convenience. However, their use comes with certain health implications.

Cancer Risks Associated with Combined Oral Contraceptives

Since 2005, research has consistently shown that combined oral contraceptives are linked to an increased risk of certain types of cancer. The IARC's classification is based on extensive studies that have identified specific risks:

  • Breast Cancer: Combined oral contraceptives have been shown to increase the risk of both in situ (confined to the original site) and invasive breast cancer. This risk is more pronounced with long-term use and in younger women.
  • Cervical Cancer: The use of these contraceptives is also associated with an elevated risk of both in situ and invasive cervical cancer. This risk is particularly significant for women who have certain risk factors, such as HPV infection.
  • Liver Cancer: There is sufficient evidence to suggest that combined oral contraceptives can cause cancer of the liver. This risk is generally lower but still noteworthy.

Progestogen-Only Contraceptives: Are They Safer?

Progestogen-only formulations, often referred to as "mini-pills," also come with their own set of risks. While they do not contain oestrogen, which is often the hormone linked to higher cancer risks in combined pills, they are not completely free from carcinogenic concerns. The IARC's conclusions about combined oral contraceptives also apply to progestogen-only formulations, indicating that they, too, can increase the risk of cancer.

Practical Tips for Users of Oral Contraceptives

Consult with a Healthcare Provider

Anyone considering the use of oral contraceptives should discuss the potential risks with a healthcare provider. This discussion should include a review of personal and family medical history, as well as any existing risk factors for cancer.

Regular Check-Ups

Regular medical check-ups and screenings are essential for anyone using oral contraceptives. These check-ups can help detect any early signs of cancer, allowing for timely intervention and treatment.

Alternative Contraceptive Methods

Women who are at a higher risk of cancer may want to consider alternative contraceptive methods. These can include barrier methods, IUDs, or non-hormonal contraceptive patches. Consulting with a healthcare provider can help in making an informed decision.

Monitoring Symptoms

It is crucial to be aware of any changes in the body that may indicate a potential health issue. Regular breast and pelvic examinations, along with self-examinations, can help in the early detection of cancer.

Important Takeaways

Balancing Benefits and Risks

While the risks are significant, it is also important to note the benefits of oral contraceptives, such as preventing unwanted pregnancies and treating certain menstrual disorders. Balancing these benefits against the potential risks is crucial for making informed decisions.

Individual Risks and Benefits

The impact of oral contraceptives on cancer risk can vary from person to person. Factors such as age, genetic predisposition, and overall health play a significant role. Therefore, a one-size-fits-all approach is not suitable when it comes to contraception.

Conclusion

The association between combined oestrogen-progestogen oral contraceptives and cancer risks is a reality that cannot be overlooked. While the evidence is clear, it is also important to consider individual circumstances and consult with healthcare providers to make informed decisions. By staying informed and vigilant, individuals can better navigate the complexities of contraceptive use and its potential health implications.

Answers

FAQ

The IARC's Group 1 classification indicates that there is sufficient evidence to conclude that combined birth control pills can cause cancer in humans. This means the risk is known and established, similar to other substances in this group, like asbestos and tobacco.

Mentioned

Products

birth control pills
Discussion

Comments

Be the first to comment.

Similar reads based on topic and creator.

Recent articles

Fresh deep dives from the latest Reels we unpacked.

View all